0001140361-20-026646.txt : 20201125 0001140361-20-026646.hdr.sgml : 20201125 20201125192607 ACCESSION NUMBER: 0001140361-20-026646 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201119 FILED AS OF DATE: 20201125 DATE AS OF CHANGE: 20201125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sooch Mina CENTRAL INDEX KEY: 0001674006 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34079 FILM NUMBER: 201352442 MAIL ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ocuphire Pharma, Inc. CENTRAL INDEX KEY: 0001228627 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113516358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 37000 GRAND RIVER AVE. STREET 2: SUITE 120 CITY: FARMINGTON HILLS STATE: MI ZIP: 48335 BUSINESS PHONE: 248-681-9815 MAIL ADDRESS: STREET 1: 37000 GRAND RIVER AVE. STREET 2: SUITE 120 CITY: FARMINGTON HILLS STATE: MI ZIP: 48335 FORMER COMPANY: FORMER CONFORMED NAME: REXAHN PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20050516 FORMER COMPANY: FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC DATE OF NAME CHANGE: 20030423 4 1 form4.xml FORM 4 X0306 4 2020-11-19 0001228627 Ocuphire Pharma, Inc. OCUP 0001674006 Sooch Mina C/O OCUPHIRE PHARMA, INC. 37000 GRAND RIVER AVE, SUITE 120 FARMINGTON HILLS MI 48335 true true President and CEO Common Stock 2020-11-19 4 P 0 11524 A 800044 D Series A Warrant (right to buy) 4.4795 2020-11-19 4 P 0 17413 A 2020-11-19 2025-11-19 Common Stock 17413 17413 D Series B Warrant (right to buy) 0.0001 2020-11-19 4 P 0 2046 A 2020-11-19 2022-01-28 Common Stock 2046 2046 D The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $65,000. Subject to adjustment based on certain price reset provisions. /s/ Emily J. Johns, by Power of Attorney 2020-11-25